Literature DB >> 22427119

Bladder expression of CD cell surface antigens and cell-type-specific transcriptomes.

Alvin Y Liu1, Ricardo Z N Vêncio, Laura S Page, Melissa E Ho, Michelle A Loprieno, Lawrence D True.   

Abstract

Many cell types have no known functional attributes. In the bladder and prostate, basal epithelial and stromal cells appear similar in cytomorphology and share several cell surface markers. Their total gene expression (transcriptome) should provide a clear measure of the extent to which they are alike functionally. Since urologic stromal cells are known to mediate organ-specific tissue formation, these cells in cancers might exhibit aberrant gene expression affecting their function. For transcriptomes, cluster designation (CD) antigens have been identified for cell sorting. The sorted cell populations can be analyzed by DNA microarrays. Various bladder cell types have unique complements of CD molecules. CD9(+) urothelial, CD104(+) basal and CD13(+) stromal cells of the lamina propria were therefore analyzed, as were CD9(+) cancer and CD13(+) cancer-associated stromal cells. The transcriptome datasets were compared by principal components analysis for relatedness between cell types; those with similarity in gene expression indicated similar function. Although bladder and prostate basal cells shared CD markers such as CD104, CD44 and CD49f, they differed in overall gene expression. Basal cells also lacked stem cell gene expression. The bladder luminal and stromal transcriptomes were distinct from their prostate counterparts. In bladder cancer, not only the urothelial but also the stromal cells showed gene expression alteration. The cancer process in both might thus involve defective stromal signaling. These cell-type transcriptomes provide a means to monitor in vitro models in which various CD-isolated cell types can be combined to study bladder differentiation and bladder tumor development based on cell-cell interaction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22427119      PMCID: PMC3367057          DOI: 10.1007/s00441-012-1383-y

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  37 in total

Review 1.  Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors.

Authors:  G R Cunha; E T Alarid; T Turner; A A Donjacour; E L Boutin; B A Foster
Journal:  J Androl       Date:  1992 Nov-Dec

2.  Plasticity of the urothelial phenotype: effects of gastro-intestinal mesenchyme/stroma and implications for urinary tract reconstruction.

Authors:  Y Li; W Liu; S W Hayward; G R Cunha; L S Baskin
Journal:  Differentiation       Date:  2000-10       Impact factor: 3.880

3.  The tissue organization field theory of cancer: a testable replacement for the somatic mutation theory.

Authors:  Ana M Soto; Carlos Sonnenschein
Journal:  Bioessays       Date:  2011-05       Impact factor: 4.345

4.  Differential Inductive Signaling of CD90 Prostate Cancer-Associated Fibroblasts Compared to Normal Tissue Stromal Mesenchyme Cells.

Authors:  Laura E Pascal; Junkui Ai; Ricardo Z N Vêncio; Eneida F Vêncio; Yong Zhou; Laura S Page; Lawrence D True; Zhou Wang; Alvin Y Liu
Journal:  Cancer Microenviron       Date:  2011-01-07

5.  CD24 overexpression in cancer development and progression: a meta-analysis.

Authors:  Ju-Han Lee; Seo-Hee Kim; Eung-Seok Lee; Young-Sik Kim
Journal:  Oncol Rep       Date:  2009-11       Impact factor: 3.906

6.  Directed differentiation of embryonic stem cells into bladder tissue.

Authors:  Siam Oottamasathien; YongQing Wang; Karin Williams; Omar E Franco; Marcia L Wills; John C Thomas; Katrina Saba; Ali-Reza Sharif-Afshar; John H Makari; Neil A Bhowmick; Romano T DeMarco; Susan Hipkens; Mark Magnuson; John W Brock; Simon W Hayward; John C Pope; Robert J Matusik
Journal:  Dev Biol       Date:  2007-01-12       Impact factor: 3.582

7.  Temporal expression profiling of the effects of secreted factors from prostate stromal cells on embryonal carcinoma stem cells.

Authors:  Laura E Pascal; Ricardo Z N Vêncio; Young Ah Goo; Laura S Page; Christina P Shadle; Alvin Y Liu
Journal:  Prostate       Date:  2009-09-01       Impact factor: 4.104

Review 8.  Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.

Authors:  H Bonkhoff; K Remberger
Journal:  Prostate       Date:  1996-02       Impact factor: 4.104

9.  Gene expression profiling of noninvasive primary urothelial tumours using microarrays.

Authors:  M Aaboe; N Marcussen; K M-E Jensen; T Thykjaer; L Dyrskjøt; T F Orntoft
Journal:  Br J Cancer       Date:  2005-11-14       Impact factor: 7.640

Review 10.  The urologic epithelial stem cell database (UESC) - a web tool for cell type-specific gene expression and immunohistochemistry images of the prostate and bladder.

Authors:  Laura E Pascal; Eric W Deutsch; David S Campbell; Martin Korb; Lawrence D True; Alvin Y Liu
Journal:  BMC Urol       Date:  2007-12-11       Impact factor: 2.264

View more
  12 in total

1.  Intestinal protein expression profile identifies inflammatory bowel disease and predicts relapse.

Authors:  Jun Shen; Yuqi Qiao; Zhihua Ran; Tianrong Wang; Jiangtao Xu; Jinsun Feng
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15

Review 2.  Reprogramming of prostate cancer cells--technical challenges.

Authors:  Gisely T Borges; Eneida F Vêncio; Ricardo Z N Vêncio; Robert L Vessella; Carol B Ware; Alvin Y Liu
Journal:  Curr Urol Rep       Date:  2015-01       Impact factor: 3.092

3.  Synergistic relationship between dipeptidyl peptidase IV and neutral endopeptidase expression and the combined prognostic significance in osteosarcoma patients.

Authors:  Hongtao Zhang; Haibin Lin; Xiaoqiong Mo; Guoli Chen; Lijun Lin
Journal:  Med Oncol       Date:  2013-05-18       Impact factor: 3.064

4.  Melphalan-flufenamide is cytotoxic and potentiates treatment with chemotherapy and the Src inhibitor dasatinib in urothelial carcinoma.

Authors:  Kristina Viktorsson; Carl-Henrik Shah; Therese Juntti; Petra Hååg; Katarzyna Zielinska-Chomej; Adam Sierakowiak; Karin Holmsten; Jessica Tu; Jack Spira; Lena Kanter; Rolf Lewensohn; Anders Ullén
Journal:  Mol Oncol       Date:  2016-01-02       Impact factor: 6.603

5.  A multiplex assay to measure RNA transcripts of prostate cancer in urine.

Authors:  Sue-Ing Quek; Melissa E Ho; Michelle A Loprieno; William J Ellis; Nathan Elliott; Alvin Y Liu
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

6.  IL22 regulates human urothelial cell sensory and innate functions through modulation of the acetylcholine response, immunoregulatory cytokines and antimicrobial peptides: assessment of an in vitro model.

Authors:  Phong T Le; Meghan M Pearce; Shubin Zhang; Edward M Campbell; Cynthia S Fok; Elizabeth R Mueller; Cynthia A Brincat; Alan J Wolfe; Linda Brubaker
Journal:  PLoS One       Date:  2014-10-29       Impact factor: 3.240

7.  Bladder cancer cells secrete while normal bladder cells express but do not secrete AGR2.

Authors:  Melissa E Ho; Sue-Ing Quek; Lawrence D True; Roland Seiler; Achim Fleischmann; Lora Bagryanova; Sara R Kim; David Chia; Lee Goodglick; Yoshiko Shimizu; Charles J Rosser; Yuqian Gao; Alvin Y Liu
Journal:  Oncotarget       Date:  2016-03-29

8.  HAfTs are novel lncRNA transcripts from aflatoxin exposure.

Authors:  B Alex Merrick; Justin S Chang; Dhiral P Phadke; Meredith A Bostrom; Ruchir R Shah; Xinguo Wang; Oksana Gordon; Garron M Wright
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

9.  Urothelial organoids originating from Cd49fhigh mouse stem cells display Notch-dependent differentiation capacity.

Authors:  Catarina P Santos; Eleonora Lapi; Jaime Martínez de Villarreal; Laura Álvaro-Espinosa; Asunción Fernández-Barral; Antonio Barbáchano; Orlando Domínguez; Ashley M Laughney; Diego Megías; Alberto Muñoz; Francisco X Real
Journal:  Nat Commun       Date:  2019-09-27       Impact factor: 14.919

10.  High expression of AGR2 in lung cancer is predictive of poor survival.

Authors:  Mohammed Alavi; Vei Mah; Erin L Maresh; Lora Bagryanova; Steve Horvath; David Chia; Lee Goodglick; Alvin Y Liu
Journal:  BMC Cancer       Date:  2015-10-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.